Ace:
News
Day care and treatment
The United States approves the use of Aducanumab: a treatment for Alzheimer's disease
11/06/2021
Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.
6 reasons to start an Alzheimer's diagnosis at Fundació ACE
22/03/2021Awareness
There is no opportune or adequate moment to face a diagnosis of dementia or Alzheimer's, but in doing so it is vitally important to have a first-rate medical team, capable of accompanying and responding to the doubts and challenges.
Blog | Stroke and its consequences
17/03/2021Awareness
One of the most frequent neurological pathologies that has the greatest impact on the population is stroke or cerebrovascular disease. To get an idea of how common it is, it is said that in Spain a stroke occurs every 6 minutes.
Carla Abdelnour participates in the AD/PD 2021 congress
10/03/2021Research
Carla Abdelnour, neurologist at Fundació ACE, speaks at the 15th international conference on Alzheimer's and Parkinson's diseases (AD / PD) to discuss the future prospects of Alzheimer's dementia
Are women more at risk of developing Alzheimer's?
08/03/2021Research
Alzheimer's dementia has a prevalence of 7.1% in women and 3.3% in men over 55 years of age. In other words, women have twice the risk of developing this type of cognitive impairment compared to men.
The Caregiver’s Space, essential during the pandemic
04/03/2021News
Since 2019, The Fundació ACE’s Social Work Area organises different workshops for family members and caregivers to share concerns, doubts, advices, strategies and, above all, to obtain direct support from Fundació ACE professionals.